Articles related to FDA

In the fast-evolving landscape of oncology treatment, a new study reveals oncologists’ unique stance on FDA approval processes, emphasizing the importance of timely access to potentially life-saving drugs despite conventional evidentiary standards.

The FDA’s recent update to Paxlovid’s EUA ensures a seamless transition to NDA-labeled nirmatrelvir+ritonavir for treating high-risk pediatric patients, reflecting a commitment to adaptability and patient care in the ongoing fight against COVID-19.

In light of the voluntary recall of Neptune’s Fix due to its dangerous ingredient, tianeptine, healthcare professionals should be vigilant in advising patients against the use of unregulated supplements and emphasize the importance of FDA-approved treatments.

With more than 27,000 doses administered, CAR T-cell therapies represent a breakthrough in treating hematologic malignancies, though emerging reports of secondary T-cell cancers post-treatment highlight the importance of long-term patient monitoring and reporting.

With FDA-approved features in wearable devices for heart health monitoring and the advent of home test kits for conditions like anemia, clinicians now have innovative tools at their disposal to enhance patient care and autonomy.

HyQvia, now FDA-approved for CIDP, shows a significant reduction in relapse rates, presenting an effective subcutaneous alternative to IVIG infusions.